Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;113:995-1004
Published online before print February 13, 2006, doi: 10.1161/CIRCULATIONAHA.105.583351
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
113/7/995    most recent
CIRCULATIONAHA.105.583351v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhao, W.
Right arrow Articles by Kranias, E. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhao, W.
Right arrow Articles by Kranias, E. G.
Related Collections
Right arrow Contractile function
Right arrow Hypertrophy
Right arrow Animal models of human disease
Right arrow Calcium cycling/excitation-contraction coupling
Right arrow Gene expression
Right arrow Gene regulation
Right arrow Genetically altered mice

(Circulation. 2006;113:995-1004.)
© 2006 American Heart Association, Inc.


Molecular Cardiology

The Presence of Lys27 Instead of Asn27 in Human Phospholamban Promotes Sarcoplasmic Reticulum Ca2+-ATPase Superinhibition and Cardiac Remodeling

Wen Zhao, MD, PhD; Qunying Yuan, MD; Jiang Qian, MD; Jason R. Waggoner, PhD; Anand Pathak, PhD; Guoxiang Chu, MD, PhD; Bryan Mitton, BS; Xiaoyin Sun, MD; Jay Jin, BS; Julian C. Braz, PhD; Harvey S. Hahn, MD; Yehia Marreez, MD; Faisal Syed, MD; Piero Pollesello, PhD; Arto Annila, PhD; Hong-Sheng Wang, PhD; Jo El J. Schultz, PhD; Jeffery D. Molkentin, PhD; Stephen B. Liggett, MD; Gerald W. Dorn, II, MD; Evangelia G. Kranias, PhD

From the Departments of Pharmacology & Cell Biophysics (W.Z., Q.Y., J.Q., J.R.W., A.P., G.C., B.M., X.S., J.J., J.C.B., H.-S.W., J.E.J.S., E.G.K.), Internal Medicine (H.S.H., Y.M., F.S., G.W.D.), and Medicine (S.B.L.), University of Cincinnati College of Medicine, Cincinnati, Ohio; Department of Pediatrics (J.C.B., J.D.M.), University of Cincinnati, Children Hospital Medical Center, Cincinnati, Ohio; Cardiovascular Research (P.P.), Orion Pharma, Espoo, Finland; and Department of Physical Sciences (A.A.), University of Helsinki, Helsinki, Finland.

Correspondence to Evangelia G. Kranias, PhD, Academy of Athens, Foundation of Biomedical Research, Department of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, Cincinnati, OH 45267-0575. E-mail Litsa.Kranias{at}uc.edu

Received August 16, 2005; revision received December 6, 2005; accepted December 14, 2005.

Background— Phospholamban (PLN) is an inhibitor of the Ca2+ affinity of sarcoplasmic reticulum (SR) Ca2+-ATPase (SERCA2). The amino acid sequence of PLN is highly conserved, and although all species contain asparagine (Asn), human PLN is unique in containing lysine (Lys) at amino acid 27.

Methods and Results— Human PLN was introduced in the null background. Expression of human PLN, at similar levels to mouse wild-type PLN, resulted in significant decreases in the affinity of SERCA2 for Ca2+, attributed to unique spatial conformation of this PLN form and increases in its monomeric active unit compared with mouse PLN. The increased inhibition by human PLN was associated with attenuated cardiac contractility in the intact-animal, organ, and cardiomyocyte levels and with depressed calcium kinetics. These inhibitory effects could not be fully reversed even on maximal isoproterenol stimulation. There were no alterations in the expression levels of SERCA2, calsequestrin, ryanodine receptor, and FKBP12, although the sodium/calcium exchanger and the L-type Ca2+ channel expression levels were upregulated. The depressed function resulted in increased heart/body weight ratios and phosphorylation levels of Akt, p38, and Erk1/2.

Conclusions— Human PLN may play a more inhibitory role than that of other species in Ca2+ cycling. Expression of human PLN in the mouse is compensated by alterations in Ca2+-handling proteins and cardiac remodeling in an effort to normalize cardiac contractility. Thus, the unique amino acid sequence of human PLN may be critical in maintaining a high cardiac reserve, which is of paramount importance in the regulation of human cardiac function.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
CirculationHome page
Q. Yuan, G.-C. Fan, M. Dong, B. Altschafl, A. Diwan, X. Ren, H. H. Hahn, W. Zhao, J. R. Waggoner, L. R. Jones, et al.
Sarcoplasmic Reticulum Calcium Overloading in Junctin Deficiency Enhances Cardiac Contractility but Increases Ventricular Automaticity
Circulation, January 23, 2007; 115(3): 300 - 309.
[Abstract] [Full Text] [PDF]